Pharmafile Logo

News and Press Releases

Centauri Therapeutics publishes proof-of-concept data demonstrating activity of a novel bifunctional immunotherapy against Gram-negative bacterial infections

Paper presents the first pre-clinical application of endogenous antibody recruitment to address multi-drug resistant Gram-negative infections Novel bifunctional molecule based on Alphamer platform demonstrated direct, broad-spectrum antibacterial activity in vitro...

Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: June 10, 2025

Centauri
info@centauritherapeutics.com
Discovery Park, Sandwich CT13 9ND

ESCMID Global 2025: Shionogi presents real-world data demonstrating better clinical outcomes when Fetcroja / Fetroja (cefiderocol) is used as empiric or documented therapy as compared to salvage therapy for the treatment of Gram-negative bacterial infections

Data from five European countries demonstrates the effectiveness of cefiderocol against Gram-negative pathogens considered as high or critical priorities by the WHO, including high rates of clinical cure and day...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: April 8, 2025

SHIONOGI
contact@shionogi.eu
33 Kingsway, London, WC2B 6UF, UK

Centauri Therapeutics selects first clinical candidate, for immunotherapeutic treatment of Gram-negative bacterial infections

Lead candidate in the ABX-01 programme to progress into first-in-human clinical studies Programme designed to treat Gram-negative bacterial lung infections in the most vulnerable patients. 4 March 2025 -- London,...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 4, 2025

Centauri
info@centauritherapeutics.com
Discovery Park, Sandwich CT13 9ND

Centauri Therapeutics awarded £1M grant under new PACE programme to advance immunotherapy platform in anti-infectives

Funding to support further development of lead programme for a novel therapeutic targeting Gram-negative bacteria including Multi-Drug-Resistant strains Optimisation will also support application of the Alphamer® platform across other therapeutic...

Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: November 25, 2024

Centauri
info@centauritherapeutics.com
Discovery Park, Sandwich CT13 9ND